Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Cost Plus Drugs vs Ways2Well

Cost Plus Drugs
Graded #370

Higher grade

vs+5.600000000000001
Ways2Well
Graded #476

Lower grade

The verdict

Cost Plus Drugs takes it — 58.5/100 to 52.9/100.

Cost Plus Drugs grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Mark Cuban's transparent-pricing online pharmacy.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEven
45
45
Dose & formulationCost Plus Drugs +25
65
40
Clinical oversightCost Plus Drugs +2
67
65
Labs & monitoringWays2Well +13
51
64
FulfillmentCost Plus Drugs +18
73
55
Contract termsEven
55
55
Cost Plus Drugs · left barWays2Well · right bar

The numbers

MetricCost Plus DrugsWays2Well
WeighScore58.5/10052.9/100
GradeCC
Scorecard rank#370#476
Semaglutide$279/mo (brand Ozempic)Not disclosed
TirzepatideNot disclosedNot disclosed
CoverageAll 50 statesCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
Cost Plus Drugs

Graded #370 · C

Strengths

  • Transparent pricing: wholesale cost + 15% markup + $5 pharmacy fee, the same for everyone
  • Around $279/mo for branded Ozempic — well below typical retail list prices
  • Mark Cuban's PBM-disrupting pharmacy, praised by Forbes Health, Wired, and KFF Health News
  • Ships to all 50 states; genuine FDA-approved Novo Nordisk Ozempic, not compounded
  • Partnered with 9amHealth so you can get prescribed and fill at Cost Plus pricing

Where it loses points

  • Fulfillment only — no telehealth intake; you need a prescription from an outside clinician
  • Ozempic is FDA-indicated for type 2 diabetes, not weight management — weight-loss use is off-label
  • Wegovy availability has been spotty — check current stock before assuming it ships
  • No compounded semaglutide or tirzepatide — brand only
  • No clinical follow-up — side-effect monitoring falls to your prescribing clinician
Ways2Well

Graded #476 · C

Strengths

  • Lab-based, clinician-directed care with bloodwork and biomarker tracking
  • Compounded GLP-1 filled by its named sister pharmacy, ReviveRX
  • Established brand with a named founder (Brigham Buhler) and its own patient app

Where it loses points

  • GLP-1 weight-loss pricing is not published on the live site and is gated behind membership
  • State coverage is limited and not fully listed
  • Requires a membership and clinician protocol rather than a simple standalone GLP-1 plan

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard